Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
TCR T-cells targeting IgA- and IgG-expressing myeloma eliminate myeloma cells from HLA-A*02:01+ pts making relevant IgH in vitro, eradicate IgA+ HLA-A*02:01+ myeloma cells in vivo & reduce circulating IgA in humanized mice.”
Title: TCR T cells targeting IgA- and IgG-expressing multiple myeloma
Authors: Karolos Douvlataniotis, Aleksei Titov, Julia Zeun, Merve Bilici, Heyilimu Palashati, Waywen Loh, Even Rustad, Weiwen Yang, Trung Tran, Fridtjof Lund-Johansen, Ravi Bollineni, Jessica Kepple, Luis Huth, Ludvig Munthe, Thorstein Boxaspen, Fredrik Schjesvold, Anders Waage, Dimitrios Wagner, Katherine Bull, Joanna Hester, Fadi Issa, Eirini Giannakopoulou, Johanna Olweus
You can read the Full Article in Blood.
You can find other articles featuring Robert Z. Orlowski on OncoDaily.
